BioInfra바이오인프라
199730 · KOSDAQ · ₩199730 · 바이오인프라
₩1,350▼ ₩12 (0.88%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Gross margin | — | — | — | 31.7% | 39.4% |
| Operating margin | — | — | — | 4.3% | 18.0% |
| Net margin | — | — | — | 6.6% | 17.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue growth | — | — | — | −15.0% | — |
| Operating income growth | — | — | — | −79.5% | — |
| Net income growth | +9.2% | −129.7% | −298.6% | −67.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Return on equity | −57.0% | −41.4% | −12.9% | 7.7% | 34.8% |
| Return on assets | −24.0% | −24.0% | −9.0% | 5.0% | 19.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Liabilities to equity | 171.4% | 112.0% | 49.2% | 38.4% | 82.0% |
| Net debt to equity | 46.6% | — | — | — | — |
| Current ratio | 58.1% | 68.6% | 160.2% | 252.3% | 201.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: BioInfra / 바이오인프라 / 199730 / KRX:199730
Source: KRX statistical information